The long-term goal of a fully automated insulin delivery (AID) system that operates without user input to maintain glucose levels within target range remains a future aspiration and may never be fully ...

Early clinical trials established the safety and feasibility of closed-loop insulin delivery, but the 2019 iDCL trial1 marked the first large, outpatient, randomised, controlled trial to show a ...

MANCHESTER, N.H. and GERMANTOWN, Md., April 29, 2025 (GLOBE NEWSWIRE) -- Sequel Med Tech, LLC, a company developing state-of-the-art insulin delivery technologies, and Senseonics Holdings, Inc. (NYSE ...

TORONTO — Clinical trials have shown that many automated insulin delivery (AID) systems are safe and effective for nonpregnant patients with type 1 diabetes (T1D). They are associated with improved ...

New research from Washington State University in collaboration with five other institutions suggests that automated insulin delivery (AID) systems are safe and effective for use by older adults with ...

– Enhanced features extend automated insulin delivery (AID) to people ages 2 years and older with type 1 diabetes and adults with type 2 diabetes – Control-IQ+ automated insulin delivery technology ...

Automated insulin delivery (AID) systems are transforming how people with Type 1 diabetes manage their condition, offering tighter glucose control and more freedom in daily life. Yet, access to this ...

Over 13 weeks, adults with type 2 diabetes using an automated insulin delivery (AID) system had a 0.6-percentage point greater drop in HbA1c than controls. The AID group also spent 3.4 more hours per ...

Tandem Diabetes Care Announces Publication Showing Adults With Type 2 Diabetes Benefit from Automated Insulin Delivery Regardless of C-Peptide Levels This sub-analysis is the first study to evaluate ...

The MarketWatch News Department was not involved in the creation of this content. Insulin Delivery Devices Market Surges to USD 43.11 Billion by 2033 as Smart Pumps, Automated Systems & Digital ...

Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App: a strategic turning point. The company confirms its status as a global reference partner for ...